Trials / Conditions / Sickle Beta Thalassemia
Sickle Beta Thalassemia
4 registered clinical trials studyying Sickle Beta Thalassemia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease NCT05675436 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Withdrawn | Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies NCT04776850 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Completed | ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19 NCT06831799 | Hospital Universitari Vall d'Hebron Research Institute | — |
| Completed | Hepcidin Levels in Sickle Cell Disease (SCD) NCT02258997 | Kenneth Ataga, MD | — |